Related references
Note: Only part of the references are listed.IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms
Johanna Melo-Cardenas et al.
BLOOD (2022)
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling
Daniel A. C. Fisher et al.
LEUKEMIA (2019)
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms
Maria Kleppe et al.
CANCER CELL (2018)
Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow
Shoko Nakayama et al.
HUMAN PATHOLOGY (2017)
Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors
Simon Haas et al.
CELL STEM CELL (2015)
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
Ayalew Tefferi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-13 Signaling and Its Role in Asthma
Efren L. Rael et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2011)
Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice
H Chagraoui et al.
BLOOD (2002)
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1
CG Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
